Aprea Therapeutics (APRE) Misses Q3 EPS by 47c
Aprea Therapeutics (NASDAQ: APRE) reported Q3 EPS of ($0.47). Revenue for the quarter came in at $1.84 million.
For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.
Aprea Therapeutics (NASDAQ: APRE) reported Q3 EPS of ($0.47). Revenue for the quarter came in at $1.84 million.
For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.